Showing results (221-230 of 390) with videos related to

Sort By:
Pageof 39
Cancer Immunology, Immunotherapy : CII|January 18, 2019
The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trialCharlotte M Huijts, Sinéad M Lougheed, Zuhir Bodalal, et al.
Targeted Oncology|March 1, 2014
Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CTMarye J Boers-Sonderen, Lioe-Fee de Geus-Oei, Ingrid M E Desar, et al.
Frontiers in Physiology|November 14, 2019
Corrigendum: Normal Values of Corrected Heart-Rate Variability in 10-Second Electrocardiograms for All AgesMarten E van den Berg, Peter R Rijnbeek, Maartje N Niemeijer, et al.
British Journal of Clinical Pharmacology|May 14, 2017
Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanibNienke A G Lankheet, Ingrid M E Desar, Sasja F Mulder, et al.
British Journal of Cancer|December 25, 2013
Pazopanib exposure decreases as a result of an ifosfamide-dependent drug-drug interaction: results of a phase I studyP Hamberg, M J Boers-Sonderen, W T A van der Graaf, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|November 25, 2016
Using a semi-conductor sequencing-based panel for genotyping of HPV-positive and HPV-negative oropharyngeal cancer: a retrospective pilot studyJ C Ham, B B J Tops, C M L Driessen, et al.
Neuro-Oncology|October 24, 2012
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastomaEnrico Franceschi, Roger Stupp, Martin J van den Bent, et al.
Frontiers in Physiology|May 15, 2018
Normal Values of Corrected Heart-Rate Variability in 10-Second Electrocardiograms for All AgesMarten E van den Berg, Peter R Rijnbeek, Maartje N Niemeijer, et al.
International Journal of Clinical Pharmacy|November 10, 2019
Economic impact of Patient's Own Medication use during hospitalisation: a multicentre pre-post implementation studyLoes J M van Herpen-Meeuwissen, Bart J F van den Bemt, Hieronymus J Derijks, et al.
BMC Palliative Care|September 8, 2021
Experiences of bereaved family caregivers with shared decision making in palliative cancer treatment: a qualitative interview studySanne P C van Oosterhout, Daisy J M Ermers, Floor K Ploos van Amstel, et al.
Pageof 39